Stocks
Exact Sciences CorporationEXAS
NASDAQHealthcareDiagnostics & Research$103.57+0.29%
A molecular diagnostics company focused on cancer screening and precision oncology testing, best known for its stool-based colorectal cancer screening test, Cologuard. The firm develops and commercializes tests that use DNA and other biomarkers to detect cancer and guide treatment decisions. Investo...
Market Cap: $19.8B52W Range: $38.81 – $103.75
This page tracks all publicly disclosed congressional trades in Exact Sciences Corporation (EXAS), a company in the Healthcare sector. 6 members of Congress have disclosed trades in this stock, including 13 purchases and 18 sales. All data is sourced from STOCK Act Periodic Transaction Reports filed with the House and Senate disclosure offices.
Total Disclosures
31
Unique Politicians
6
Buys
13
Sells
18
Congressional Trading History
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2024-05-10 | Josh Gottheimer | sell | $1K – $15K |
| 2024-02-01 | Josh Gottheimer | sell | $1K – $15K |